Last €52.11 EUR
Change Today +0.098 / 0.19%
Volume 4.4K
MDT On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 1:34 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

medtronic inc (MDT) Snapshot

Open
€51.65
Previous Close
€52.01
Day High
€52.28
Day Low
€51.65
52 Week High
10/6/14 - €52.30
52 Week Low
02/5/14 - €38.85
Market Cap
51.0B
Average Volume 10 Days
10.6K
EPS TTM
--
Shares Outstanding
979.5M
EX-Date
10/1/14
P/E TM
--
Dividend
€1.22
Dividend Yield
1.66%
Current Stock Chart for MEDTRONIC INC (MDT)

medtronic inc (MDT) Details

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group’s products include pacemakers; insertable cardiac monitors; implantable defibrillators; leads and delivery systems; ablation products; electrophysiology catheters; products for the treatment of atrial fibrillation; information systems for the management of patients with cardiac rhythm disease management devices; products to reduce surgical site infections; coronary and peripheral stents and related delivery systems; therapies for uncontrolled hypertension; endovascular stent graft systems; heart valve replacement technologies; cardiac tissue ablation systems; and open heart and coronary bypass grafting surgical products. The Restorative Therapies Group offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; and systems that incorporate advanced energy surgical instruments. It also manufactures and sells image-guided surgery and intra-operative imaging systems. The Diabetes Group’s products include insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. The company serves hospitals, physicians, clinicians, and patients in approximately 140 countries. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.

49,247 Employees
Last Reported Date: 06/20/14
Founded in 1949

medtronic inc (MDT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.5M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $774.9K
Executive Vice President and Group President ...
Total Annual Compensation: $724.9K
Executive Vice President and Group President ...
Total Annual Compensation: $675.1K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $781.7K
Compensation as of Fiscal Year 2014.

medtronic inc (MDT) Key Developments

Medtronic Launches the Divergence(TM) Anterior Cervical Fusion System

Medtronic, Inc. announced the U.S. launch of the DIVERGENCE Anterior Cervical Fusion System for the treatment of single-level cervical disc disease. The DIVERGENCE System represents a new approach to one-level anterior cervical discectomy with fusion (ACDF) procedures, which traditionally use a four-hole plate and interbody fusion cage. With the DIVERGENCE(TM) System, the plate and interbody cage can be inserted simultaneously using a common set of instrumentation and one surgical technique. Traditional cervical fusion surgery requires a two-step insertion technique for the plate and interbody cage, and each implant requires its own set of instruments and its own surgical technique. In addition, the DIVERGENCE System incorporates a laterally-divergent screw insertion technique, which requires less retraction compared to the traditional medially-convergent screw insertion techniques used with other anterior cervical plating systems.

Medtronic Announces FDA Approval of Pacing Lead for Full-Body MRI Scans

Medtronic announced the U.S. Food and Drug Administration (FDA) approval of its CapSureFix Novus(TM) MRI SureScan(R) 5076 Lead for use with magnetic resonance imaging (MRI). The lead is approved for MRI scans positioned on any region of the body when paired with a Medtronic dual-chamber MR-conditional pacemaker. The 5076 lead, previously approved for use with Medtronic's non-MR-conditional pacemakers, has been well-received because of its handling and proven reliability. Since its introduction more than 10 years ago, physicians have implanted more than 3 million 5076 leads in patients. With the new FDA approval, two 5076 MRI leads can now be paired with dual-chamber Medtronic Advisa MRI(TM) or Revo MRI(TM) SureScan(R) pacemakers, allowing patients with these complete SureScan pacing systems to undergo full-body MRI scans. Medtronic 5076 MRI lead lengths approved for these scans range in length from 35cm to 85cm. Patients who previously had two 5076 leads implanted with non-MRI pacemakers will have the option to receive MRIs if MR-conditional SureScan pacemakers are implanted when replacement devices are needed. The 5076 MRI lead is the latest addition to a growing number of Medtronic devices that are approved for MRI access. These include the Medtronic SureScan pacing systems, the SureScan neurostimulation systems for the management of chronic pain, and the SynchroMed(R) II programmable drug infusion system, which are available worldwide. Additionally, the Evera MRI(TM) SureScan implantable cardioverter-defibrillator (ICD) system is investigational in the U.S.

Medtronic Latin America Presents at BioFlorida Annual Conference, Oct-14-2014 08:40 AM

Medtronic Latin America Presents at BioFlorida Annual Conference, Oct-14-2014 08:40 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: Jim Hogan, President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:GR €52.11 EUR +0.098

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.46 USD +0.03
Allergan Inc/United States $184.21 USD +0.84
Astellas Pharma Inc ¥1,598 JPY +20.50
Baxter International Inc $69.83 USD +0.73
Covidien PLC $89.64 USD +1.19
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 22.2x
Price/Sales 3.8x
Price/Book 3.3x
Price/Cash Flow 19.3x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.